Zomato के कैसे रहे Q1 Results, Experts से जानिए कैसे बनाए निवेश की रणनीति । ETNow Swadesh

ET Now Swadesh
1 Aug 202403:09

Summary

TLDRThe video script discusses stock trading insights, emphasizing the importance of technical analysis and market momentum. It highlights a stock that has crossed the 230 mark and is showing promising technical developments, with a recommendation to consider a positional buy with a strict stop loss. The script also mentions positive revenue and profit growth, improved margins, and a significant year-over-year increase. It concludes with stock picks in the pharmaceutical sector, suggesting potential for good moves post-results.

Takeaways

  • 📈 The stock has crossed the previous high of 230, indicating a strong momentum with increasing volumes.
  • 🛑 For momentum traders, a strict stop-loss at the day's low is recommended.
  • 📊 Technical indicators show a positive development, suggesting a potential target of 275-280 in two to three months.
  • 🕒 Post-results volatility is expected, so positional buyers are advised to hold with a focus on the long-term potential.
  • 💼 Revenue and profits have exceeded expectations, with a significant year-over-year EBITDA increase of over 100%.
  • 🔄 Margins have doubled from 2.4% to 4.2%, aligning with market expectations.
  • 💬 Management's commentary and press release will provide further insights on future prospects.
  • 🍽️ Zomato's performance is highlighted as having strong technical support and potential for a sharp spike post-results.
  • 💊 Sun Pharma's results were underwhelming, while other pharma stocks like Dr. Reddy's, Lupin, and Zydus showed strong performance.
  • 🔍 Keeping an eye on market developments and technical charts is crucial for making informed trading decisions.

Q & A

  • What technical levels are being discussed in the script?

    -The technical level discussed is 230, and if the stock crosses above this level, it may have momentum to go higher.

  • What is recommended for those wanting to chase the momentum?

    -For those chasing momentum, it is recommended to use a strict stop loss at the day's low and consider buying BTST (Buy Today, Sell Tomorrow).

  • What should be considered after the results are announced?

    -After results are announced, it is advised to expect some fluctuation and consider a positional buy as the stock has a strong chart structure.

  • What is the expected price target in the next two to three months?

    -The expected price target in the next two to three months is 275-280.

  • How is the overall technical development described?

    -The overall technical development is described as very positive, with strong volumes and momentum building up.

  • What are the key financial performance highlights mentioned?

    -The key financial performance highlights include better-than-expected revenue and profit, with EBITDA more than doubling year-on-year.

  • What are the specific figures for EBITDA and margins?

    -EBITDA has reached 177 crores, and margins have improved from 2.4% to 4.2%.

  • What is the market's expectation regarding margins?

    -The market expected the margin figures, which have come in line with these expectations.

  • What should viewers keep an eye on regarding the company's updates?

    -Viewers should keep an eye on management commentary and the company's press releases for further updates and insights.

  • What other stocks in the pharma sector are performing well?

    -Other well-performing stocks in the pharma sector include Dr. Reddy's, Lupin, and Zydus.

Outlines

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Mindmap

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Keywords

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Highlights

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Transcripts

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant
Rate This

5.0 / 5 (0 votes)

Étiquettes Connexes
Technical AnalysisStock InsightsMarket UpdatesFinancial ReviewInvestment TipsVolume TrendsMomentum TradingStock PicksSector AnalysisMargin TrendsRevenue Growth
Besoin d'un résumé en anglais ?